Objective: To evaluate the effect of a continuous combined oral hormone replacement therapy (HRT) on basal and post-methionine load homocysteine levels in postmenopausal women. Design: Twenty-two postmenopausal women (PMW) were randomly allocated to receive either continuous combined oral HRT (2 mg of estradiol plus 1 mg of norethisterone acetate; n = 11) or no treatment (controls, n = 11) for 6 months. A methionine oral load (0.1 g/kg body weight) was performed in each subject at time 0 and after 6 months. Serum homocysteine levels were measured by high-performance liquid chromatography in samples collected at time 0 and at 4, 8, and 24 h after the methionine load, while levels of vitamin B, (by high-performance liquid chromatography) and B,, and folate (both by ELISA) were assayed in samples collected at time 0. Results: Serum levels of glucose and body mass index increased in treated PMW, whereas folate decreased in controls. In treated PMW, basal homocysteine tended to decrease (10.6 +/- 3.3 mu mol/L vs. 9.62 +/- 2.8 mu mol/L, p = 0.062), whereas in controls it significantly increased (10.7 +/- 2.65 mu mol/L vs. 12.17 +/- 3.89 mu mol/L, p < 0.05). This increase was not significant after correction for vitamin status (p = 0.072). Homocysteine values 4 h (31.9 +/- 13.53 mu mol/L vs. 39.83 +/- 22.53 mu mol/L, p < 0.05) and 8 h (35.1 +/- 13.13 vs. 43.34 +/- 22.15 mu mol/L) after methionine, and integrated homocysteine response to methionine (392.5 +/- 133.8 mu mol/24 h vs. 458.8 +/- 104.8 mu mol/24 h; p < 0.05), were significantly reduced in HRT-treated, but not in untreated, PMW. Conclusions: Continuous combined oral HRT with 17 beta -estradiol plus norethisterone acetate reduces homocysteine levels, mainly after a methionine load. This effect seems to be independent of vitamin status and may have positive implications for the prevention of cardiovascular diseases in PMW.
|Data di pubblicazione:||2001|
|Titolo:||Continuous combined hormone replacement therapy with oral 17 beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women|
|Autore/i:||Ventura, Paolo; Cagnacci, Angelo; S., Malmusi; R., Panini; F., Baldassari; S., Arangino; Volpe, Annibale; Salvioli, Gianfranco|
|Codice identificativo ISI:||WOS:000169829500006|
|Codice identificativo Scopus:||2-s2.0-0034933193|
|Codice identificativo Pubmed:||11449082|
|Citazione:||Continuous combined hormone replacement therapy with oral 17 beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women / Ventura, Paolo; Cagnacci, Angelo; S., Malmusi; R., Panini; F., Baldassari; S., Arangino; Volpe, Annibale; Salvioli, Gianfranco. - In: MENOPAUSE. - ISSN 1072-3714. - STAMPA. - 8(2001), pp. 252-258.|
|Tipologia||Articolo su rivista|
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris